2',3'-dideoxythymidine triphosphate has been researched along with zalcitabine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abou-Taleb, N; Amblard, F; Amiralaei, S; Bassit, L; Coats, SJ; Domaoal, RA; Ehteshami, M; Khalil, A; Liu, P; Mahmoud, S; McBrayer, T; Ollinger Russell, O; Sari, O; Schinazi, RF; Schutter, C; Tao, S; Whitaker, T; Zhou, L; Zhou, S | 1 |
| Brandi, G; Carnevali, A; Fraternale, A; Magnani, M; Rossi, L; Schiavano, GF | 1 |
2 other study(ies) available for 2',3'-dideoxythymidine triphosphate and zalcitabine
| Article | Year |
|---|---|
2'-Chloro,2'-fluoro Ribonucleotide Prodrugs with Potent Pan-genotypic Activity against Hepatitis C Virus Replication in Culture.
Topics: Antiviral Agents; Cells, Cultured; Dose-Response Relationship, Drug; Genotype; Hep G2 Cells; Hepacivirus; Humans; Microbial Sensitivity Tests; Molecular Structure; Prodrugs; Ribonucleotides; Structure-Activity Relationship; Viral Nonstructural Proteins; Virus Replication | 2017 |
Effect of antiviral treatments on the bone marrow in murine aids.
Topics: Animals; Antiviral Agents; Bone Marrow; Dideoxynucleotides; Gene Products, gag; Mice; Mice, Inbred C57BL; Murine Acquired Immunodeficiency Syndrome; Thymine Nucleotides; Zalcitabine; Zidovudine | 1995 |